Monographs Not Viable for Unapproved Prescription Drug Review, FDA Says

A monograph system is not a viable approach for evaluating the safety and efficacy of prescription drugs that are marketed without FDA approval, agency officials told an overflow crowd during a Jan. 9 workshop on unapproved drugs